September 02, 2025 a 03:43 pm

MDT: Fundamental Ratio Analysis - Medtronic plc

Medtronic plc Overview

Medtronic plc, a global leader in medical technology, provides extensive device-based medical therapies. With strong portfolios in cardiovascular, medical surgical, neuroscience, and diabetes sectors, the company has positioned itself well. The stock shows potential, backed by innovative product offerings and a robust market presence.

Fundamental Rating

The fundamental rating of Medtronic plc reflects its strengths in financial health and market standing, with a focus on its cash flow and return metrics.

Category Score Visualization
Discounted Cash Flow 4
Return On Equity 4
Return On Assets 4
Debt To Equity 2
Price To Earnings 1
Price To Book 3

Historical Rating

Historical data depicts stability in Medtronic's fundamental scores, reflecting consistent financial management over time.

Date Overall DCF ROE ROA Debt/Equity P/E P/B
Current 3 4 4 4 2 1 3
2025-08-29 3 4 4 4 2 1 3

Analyst Price Targets

Analysts have set a unified price target for Medtronic plc, indicating aligned expectations regarding its market performance.

High Low Median Consensus
115 115 115 115
Medtronic Stock Chart

Analyst Sentiment

The sentiment among analysts is predominantly positive, with a strong inclination towards buying, supported by the company's strategic growth trajectory.

Recommendation Number Visualization
Strong Buy 1
Buy 27
Hold 21
Sell 0
Strong Sell 0

Conclusion

Medtronic plc exhibits a resilient financial profile, supported by a diverse product line and strategic market strategies. The company's stability in fundamentals and favorable analyst ratings position it well for future growth. However, investors should remain cautious of potential fluctuations in market conditions and regulatory environments. Overall, Medtronic provides promising opportunities with manageable risk levels for prospective stakeholders.